Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Sha

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|September 11, 1991
Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazoleJ C Pottage, B E Sha
JAMA|December 6, 2000
Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workersB E Sha, L A Proia, H A Kessler
JAMA|June 9, 1993
False-positive HIV test: implications for the patientJ F Sullivan, H A Kessler, B E Sha
AIDS (London, England)|October 8, 1999
Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1G G Olinger, F B Hashemi, B E Sha, et al.
Virology|July 11, 1998
Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysisD M Takefman, B L Sullivan, B E Sha, et al.
AIDS (London, England)|July 1, 1992
Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosineJ C Pottage, C A Benson, B E Sha, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 11, 2000
Body composition in HIV-infected womenB Swanson, R C Hershow, B E Sha, et al.
The Journal of Infectious Diseases|October 21, 1998
A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancerL Al-Harthi, G T Spear, F B Hashemi, et al.
AIDS (London, England)|August 10, 2000
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapyA R Tenorio, I E Irlanda, E Narkiewicz, et al.
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patientsH Valdez, S Purvis, R Asaad, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|September 11, 1991
Development of histoplasmosis in a human immunodeficiency virus-infected patient receiving fluconazoleJ C Pottage, B E Sha
JAMA|December 6, 2000
Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workersB E Sha, L A Proia, H A Kessler
JAMA|June 9, 1993
False-positive HIV test: implications for the patientJ F Sullivan, H A Kessler, B E Sha
AIDS (London, England)|October 8, 1999
Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1G G Olinger, F B Hashemi, B E Sha, et al.
Virology|July 11, 1998
Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysisD M Takefman, B L Sullivan, B E Sha, et al.
AIDS (London, England)|July 1, 1992
Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosineJ C Pottage, C A Benson, B E Sha, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 11, 2000
Body composition in HIV-infected womenB Swanson, R C Hershow, B E Sha, et al.
The Journal of Infectious Diseases|October 21, 1998
A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancerL Al-Harthi, G T Spear, F B Hashemi, et al.
AIDS (London, England)|August 10, 2000
Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapyA R Tenorio, I E Irlanda, E Narkiewicz, et al.
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patientsH Valdez, S Purvis, R Asaad, et al.
Pageof 3